サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1303139

イメージングCRO市場- 世界の産業規模、シェア、動向、機会、予測、2017年～2027年

Imaging Clinical Research Organization Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2017-2027 Segmented By Services Offered, By Imaging Modality, By Clinical Trial Phase, By Application, By End User, By company & By Region

出版日
ページ情報
英文 119 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

イメージングCRO市場- 世界の産業規模、シェア、動向、機会、予測、2017年～2027年
出版日: 2023年07月01日
発行: TechSci Research
ページ情報: 英文 119 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界のイメージングCRO市場は、2023年から2027年の予測期間中に目覚ましい成長を遂げると予測されています。

主な要因としては、臨床試験件数の増加、研究開発費の継続的な増加、技術の広範な進歩などが市場成長を後押ししています。メディカルイメージングは、新しいライフサイエンス製品の臨床的進歩において効果的な役割を果たしています。バイオテクノロジーや製薬産業の拡大、様々な疾患を治療する新薬開発のための研究開発投資の増加は、市場産業の成長を促進すると思われます。その他の市場成長を支える要因としては、研究開発活動の活発化、研究開発費の増加、イメージングプロセスの自動化、イメージング技術の利用拡大とコンピューティング能力の向上、合併や戦略的買収の増加などが挙げられます。

メディカルイメージングによる年間臨床試験件数の増加が市場成長を支えます。

臨床研究の増加による臨床試験件数の増加が市場の成長を後押ししています。イメージングCROは、重要な領域に関する大量の情報と洞察を提供することで、研究者を支援しています。また、医療機器、バイオテクノロジー、製薬など様々な産業に品質、費用対効果、製造能力を付加しています。臨床試験におけるメディカルイメージングの重要性の高まりが、市場の成長を後押ししています。Keosys Medical Imagingの記事によると、2018年、毎年実施される臨床試験の総数は、2010年と比較して2020年にはほぼ倍増しています。

市場成長を促進する研究開発活動と支出の増加

研究開発（R&D）活動の活発化が市場の成長を後押ししています。放射線学と画像科学の分野における調査の増加は、重要な技術の創出に役立っているほか、人間の異常や病気を特定し治療するための機器を使用する最新技術に磨きをかけています。現在では、メディカルイメージングの助けを借りて、医学的、外科的、行動学的介入を評価するために様々な臨床研究が行われています。また、研究開発費の継続的な増加が市場の成長を促進しています。

イメージングCROプロセスにおける自動化の採用増加

ここ数年、技術の急速な進歩が市場の成長を後押ししています。イメージングCROプロセスの自動化などの進歩は、バイオテクノロジーや製薬業界に大きな影響を与えています。イメージングCROプロセスの自動化は、プロセスを効果的かつ効率的にします。そのため、イメージングプロセスにおける自動化の採用が増加しており、市場の成長を後押ししています。例えば、2021年、アボット社は、同社の新しいUltreonソフトウェアによって運用される最新の光コヒーレンストモグラフィ（OCT）イメージングプラットフォームのFDA認可を取得したと発表しました。この先進イメージング・ソフトウェアは、OCTと人工知能を組み合わせ、冠動脈血流と閉塞の強化された包括的なビューを医師に提供し、医師の意思決定を支援し、治療のための最良のルートを提供します。

利用可能なカスタマイズ

TechSciリサーチは、所定の市場データを用いて、企業の特定のニーズに応じたカスタマイズを提供します。レポートでは以下のカスタマイズが可能です：

企業情報

  • 追加市場参入企業（最大5社）の詳細分析とプロファイリング

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 COVID-19が世界のイメージングCRO市場に与える影響

第5章 顧客の声

第6章 世界のイメージングCRO市場の展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 提供サービス別
    • イメージングモダリティ別
    • 臨床試験フェーズ別
    • アプリケーション別
    • エンドユーザー別
    • 地域別
    • 企業別
  • 市場マップ

第7章 北米のイメージングCRO市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • 提供サービス別
    • イメージングモダリティ別
    • 臨床試験フェーズ別
    • アプリケーション別
    • エンドユーザー別
    • 国別
  • 北米国別分析
    • 米国
    • カナダ
    • メキシコ

第8章 欧州のイメージングCRO市場の展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 提供サービス別
    • イメージングモダリティ別
    • 臨床試験フェーズ別
    • アプリケーション別
    • エンドユーザー別
    • 国別
  • 欧州国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第9章 アジア太平洋地域のイメージングCRO市場の展望

  • 市場規模と予測
    • 金額ベース
  • 市場シェアと予測
    • 提供サービス別
    • イメージングモダリティ別
    • 臨床試験フェーズ別
    • アプリケーション別
    • エンドユーザー別
    • 国別
  • アジア太平洋地域国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア

第10章 南米のイメージングCRO市場の展望

  • 市場規模と予測
    • 金額ベース
  • 市場シェアと予測
    • 提供サービス別
    • イメージングモダリティ別
    • 臨床試験フェーズ別
    • アプリケーション別
    • エンドユーザー別
    • 国別
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第11章 中東・アフリカのイメージングCRO市場の展望

  • 市場規模と予測
    • 金額ベース
  • 市場シェアと予測
    • 提供サービス別
    • イメージングモダリティ別
    • 臨床試験フェーズ別
    • アプリケーション別
    • エンドユーザー別
    • 国別
  • MEA：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • トルコ
    • エジプト

第12章 市場力学

  • 促進要因
  • 課題

第13章 市場動向と発展

第14章 競合情勢

  • Laboratory Corporation of America Holdings
  • IXICO PLC
  • ICON plc
  • The Micron Group
  • Medpace Holdings, Inc.
  • Radiant Sage LLC
  • Biomedical Systems Corporation
  • Worldcare Clinical, LLC
  • Imaging Endpoints LLC
  • Parexel International Corporation

第15章 戦略的提言

目次
Product Code: 14156

The global imaging clinical research organization (CRO) market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include the growing number of clinical trials, continuous growth in R&D spending, and extensive advancement in technology are impelling the growth of the market. Medical imaging plays an effective role in the clinical advancement of novel life science products. The expansion of the biotechnology and pharmaceutical industries, along with increased research and development investments for developing new drugs to treat various diseases, is likely to drive the market industry growth. The other factors supporting the market's growth are, rise in R&D activities, increasing R&D expenditure, a rise in automation of imaging process, increasing usage of imaging technology and the enhanced power of computing, and a growing number of mergers and strategic acquisitions.

An increase in the Annual Number of Clinical Trials with Medical Imaging supports Market Growth.

A growing number of clinical trials due to the rise in clinical research is augmenting the growth of the market. Imaging Clinical Research Organizations help researchers by providing massive amounts of information and insights into key areas. They are adding quality, cost-effectiveness, and manufacturing capacity to various industries such as medical devices, biotechnology, and pharmaceutical. The growing significance of medical imaging in clinical trials is fueling the growth of the market. According to a Keosys Medical Imaging article, in 2018, the total number of clinical trials performed each year almost doubled in 2020 compared to 2010.

Growth in R&D Activities and spending to foster the Market Growth

The rise in research and development (R&D) activities is bolstering the growth of the market. Rising research in the field of radiology and imaging sciences are helping to generate critical technologies, as well as honed modern techniques for using equipment to identify and treat abnormalities and disease in humans. Nowadays, various clinical studies are done to evaluate medical, surgical, and behavioral interventions with the help of medical imaging. Also, continuous growth in R&D spending is facilitating the growth of the market.

Increasing Adoption of Automation in Imaging CRO Process

Over the past few years, rapid advancements in technology are propelling the growth of the market. Advancements such as automation in the Imaging CRO process are making a huge impact on the biotechnology and pharmaceutical industries. Automation in the imaging CRO process makes the process effective and efficient; also, it helps to control errors and minimize time. Thus, the increasing adoption of automation in the imaging process encourages the growth of the market. For instance, in 2021, Abbott announced that it had received FDA clearance for the latest optical coherence tomography (OCT) imaging platform operated by the company's new Ultreon Software. This advanced imaging software combines OCT with artificial intelligence to offer physicians an enhanced, comprehensive view of coronary blood flow and blockages to aid physician decision-making and offer the best route for treatment.

Market Segmentation

The global imaging clinical research organization (CRO) market is segmented into services offered, imaging modality, clinical trial phase, application, end user, and company. Based on the services offered, the market is divided into imaging acquisition and protocol development, application design, image collection, and quality control, digital image conversion, support and maintenance, and others. Based on imaging modality, the market is divided into computed tomography (CT) scans, magnetic resonance imaging (MRI), positron emission tomography (PET), and others. Based on the clinical trial phase, the market is divided into Phase 1, phase 2, and Phase 3. Based on application, the market is divided into oncology, neurology, cardiovascular, ophthalmology, and others. Based on end-user, the market is divided into pharmaceutical & biotechnology companies, medical device manufacturers, academic & research institutions, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to the rising number of clinical studies in the country.

Market Players

Laboratory Corporation of America Holdings, IXICO PLC, ICON plc, The Micron Group, Medpace Holdings, Inc., Radiant Sage LLC, Biomedical Systems Corporation, Worldcare Clinical, LLC, Imaging Endpoints LLC, and Parexel International Corporation are some of the leading companies operating in the market.

Report Scope

In this report, global imaging clinical research organization (CRO) market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Imaging Clinical Research Organization (CRO) Market, By Services Offered:

  • Imaging Acquisition and Protocol Development
  • Application Design
  • Image Collection and Quality Control
  • Digital Image Conversion
  • Support and Maintenance
  • Others

Imaging Clinical Research Organization (CRO) Market, By Imaging Modality:

  • Computed Tomography (CT) Scan
  • Magnetic Resonance Imaging (MRI)
  • Positron Emission Tomography (PET)
  • Others

Imaging Clinical Research Organization (CRO) Market, By Clinical Trial Phase:

  • Phase 1
  • Phase 2
  • Phase 3

Imaging Clinical Research Organization (CRO) Market, By application:

  • Oncology
  • Neurology
  • Cardiovascular
  • Ophthalmology
  • Others

Imaging Clinical Research Organization (CRO) Market, By End User:

  • Pharmaceutical & Biotechnology Companies
  • Medical Device Manufacturers
  • Academic & Research Institutions
  • Others

Imaging Clinical Research Organization (CRO) Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Europe & CIS
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Turkey
    • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Imaging Clinical Research Organization (CRO) Market

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Imaging Clinical Research Organization (CRO) Market

5. Voice of Customer

6. Global Imaging Clinical Research Organization (CRO) Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Services Offered (Imaging Acquisition and Protocol Development, Application Design, Image Collection and Quality Control, Digital Image Conversion, Support and Maintenance, Others)
    • 6.2.2. By Imaging Modality (Computed Tomography (CT) Scan, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Others)
    • 6.2.3. By Clinical Trial Phase (Phase 1, Phase 2, Phase 3)
    • 6.2.4. By Application (Oncology, Neurology, Cardiovascular, Ophthalmology, Others)
    • 6.2.5. By End User (Pharmaceutical & Biotechnology Companies, Medical Device Manufacturers, Academic & Research Institutions, Others)
    • 6.2.6. By Region
    • 6.2.7. By Company (2021)
  • 6.3. Market Map

7. North America Imaging Clinical Research Organization (CRO) Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Services Offered
    • 7.2.2. By Imaging Modality
    • 7.2.3. By Clinical Trial Phase
    • 7.2.4. By Application
    • 7.2.5. By End User
    • 7.2.6. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Imaging Clinical Research Organization (CRO) Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Services Offered
        • 7.3.1.2.2. By Imaging Modality
        • 7.3.1.2.3. By Clinical Trial Phase
        • 7.3.1.2.4. By Application
        • 7.3.1.2.5. By End User
    • 7.3.2. Canada Imaging Clinical Research Organization (CRO) Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Services Offered
        • 7.3.2.2.2. By Imaging Modality
        • 7.3.2.2.3. By Clinical Trial Phase
        • 7.3.2.2.4. By Application
        • 7.3.2.2.5. By End User
    • 7.3.3. Mexico Imaging Clinical Research Organization (CRO) Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Services Offered
        • 7.3.3.2.2. By Imaging Modality
        • 7.3.3.2.3. By Clinical Trial Phase
        • 7.3.3.2.4. By Application
        • 7.3.3.2.5. By End User

8. Europe Imaging Clinical Research Organization (CRO) Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Services Offered
    • 8.2.2. By Imaging Modality
    • 8.2.3. By Clinical Trial Phase
    • 8.2.4. By Application
    • 8.2.5. By End User
    • 8.2.6. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Imaging Clinical Research Organization (CRO) Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Services Offered
        • 8.3.1.2.2. By Imaging Modality
        • 8.3.1.2.3. By Clinical Trial Phase
        • 8.3.1.2.4. By Application
        • 8.3.1.2.5. By End User
    • 8.3.2. Germany Imaging Clinical Research Organization (CRO) Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Services Offered
        • 8.3.2.2.2. By Imaging Modality
        • 8.3.2.2.3. By Clinical Trial Phase
        • 8.3.2.2.4. By Application
        • 8.3.2.2.5. By End User
    • 8.3.3. United Kingdom Imaging Clinical Research Organization (CRO) Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Services Offered
        • 8.3.3.2.2. By Imaging Modality
        • 8.3.3.2.3. By Clinical Trial Phase
        • 8.3.3.2.4. By Application
        • 8.3.3.2.5. By End User
    • 8.3.4. Italy Imaging Clinical Research Organization (CRO) Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Services Offered
        • 8.3.4.2.2. By Imaging Modality
        • 8.3.4.2.3. By Clinical Trial Phase
        • 8.3.4.2.4. By Application
        • 8.3.4.2.5. By End User
    • 8.3.5. Spain Imaging Clinical Research Organization (CRO) Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Services Offered
        • 8.3.5.2.2. By Imaging Modality
        • 8.3.5.2.3. By Clinical Trial Phase
        • 8.3.5.2.4. By Application
        • 8.3.5.2.5. By End User

9. Asia-Pacific Imaging Clinical Research Organization (CRO) Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Services Offered
    • 9.2.2. By Imaging Modality
    • 9.2.3. By Clinical Trial Phase
    • 9.2.4. By Application
    • 9.2.5. By End User
    • 9.2.6. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Imaging Clinical Research Organization (CRO) Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Services Offered
        • 9.3.1.2.2. By Imaging Modality
        • 9.3.1.2.3. By Clinical Trial Phase
        • 9.3.1.2.4. By Application
        • 9.3.1.2.5. By End User
    • 9.3.2. India Imaging Clinical Research Organization (CRO) Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Services Offered
        • 9.3.2.2.2. By Imaging Modality
        • 9.3.2.2.3. By Clinical Trial Phase
        • 9.3.2.2.4. By Application
        • 9.3.2.2.5. By End User
    • 9.3.3. Japan Imaging Clinical Research Organization (CRO) Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Services Offered
        • 9.3.3.2.2. By Imaging Modality
        • 9.3.3.2.3. By Clinical Trial Phase
        • 9.3.3.2.4. By Application
        • 9.3.3.2.5. By End User
    • 9.3.4. South Korea Imaging Clinical Research Organization (CRO) Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Services Offered
        • 9.3.4.2.2. By Imaging Modality
        • 9.3.4.2.3. By Clinical Trial Phase
        • 9.3.4.2.4. By Application
        • 9.3.4.2.5. By End User
    • 9.3.5. Australia Imaging Clinical Research Organization (CRO) Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Services Offered
        • 9.3.5.2.2. By Imaging Modality
        • 9.3.5.2.3. By Clinical Trial Phase
        • 9.3.5.2.4. By Application
        • 9.3.5.2.5. By End User

10. South America Imaging Clinical Research Organization (CRO) Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Services Offered
    • 10.2.2. By Imaging Modality
    • 10.2.3. By Clinical Trial Phase
    • 10.2.4. By Application
    • 10.2.5. By End User
    • 10.2.6. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Imaging Clinical Research Organization (CRO) Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Services Offered
        • 10.3.1.2.2. By Imaging Modality
        • 10.3.1.2.3. By Clinical Trial Phase
        • 10.3.1.2.4. By Application
        • 10.3.1.2.5. By End User
    • 10.3.2. Argentina Imaging Clinical Research Organization (CRO) Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Services Offered
        • 10.3.2.2.2. By Imaging Modality
        • 10.3.2.2.3. By Clinical Trial Phase
        • 10.3.2.2.4. By Application
        • 10.3.2.2.5. By End User
    • 10.3.3. Colombia Imaging Clinical Research Organization (CRO) Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Services Offered
        • 10.3.3.2.2. By Imaging Modality
        • 10.3.3.2.3. By Clinical Trial Phase
        • 10.3.3.2.4. By Application
        • 10.3.3.2.5. By End User

11. Middle East and Africa Imaging Clinical Research Organization (CRO) Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Services Offered
    • 11.2.2. By Imaging Modality
    • 11.2.3. By Clinical Trial Phase
    • 11.2.4. By Application
    • 11.2.5. By End User
    • 11.2.6. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Imaging Clinical Research Organization (CRO) Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Services Offered
        • 11.3.1.2.2. By Imaging Modality
        • 11.3.1.2.3. By Clinical Trial Phase
        • 11.3.1.2.4. By Application
        • 11.3.1.2.5. By End User
    • 11.3.2. Saudi Arabia Imaging Clinical Research Organization (CRO) Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Services Offered
        • 11.3.2.2.2. By Imaging Modality
        • 11.3.2.2.3. By Clinical Trial Phase
        • 11.3.2.2.4. By Application
        • 11.3.2.2.5. By End User
    • 11.3.3. UAE Imaging Clinical Research Organization (CRO) Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Services Offered
        • 11.3.3.2.2. By Imaging Modality
        • 11.3.3.2.3. By Clinical Trial Phase
        • 11.3.3.2.4. By Application
        • 11.3.3.2.5. By End User
    • 11.3.4. Turkey Imaging Clinical Research Organization (CRO) Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Services Offered
        • 11.3.4.2.2. By Imaging Modality
        • 11.3.4.2.3. By Clinical Trial Phase
        • 11.3.4.2.4. By Application
        • 11.3.4.2.5. By End User
    • 11.3.5. Egypt Imaging Clinical Research Organization (CRO) Market Outlook
      • 11.3.5.1. Market Size & Forecast
        • 11.3.5.1.1. By Value
      • 11.3.5.2. Market Share & Forecast
        • 11.3.5.2.1. By Services Offered
        • 11.3.5.2.2. By Imaging Modality
        • 11.3.5.2.3. By Clinical Trial Phase
        • 11.3.5.2.4. By Application
        • 11.3.5.2.5. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Laboratory Corporation of America Holdings
  • 14.2. IXICO PLC
  • 14.3. ICON plc
  • 14.4. The Micron Group
  • 14.5. Medpace Holdings, Inc.
  • 14.6. Radiant Sage LLC
  • 14.7. Biomedical Systems Corporation
  • 14.8. Worldcare Clinical, LLC
  • 14.9. Imaging Endpoints LLC
  • 14.10. Parexel International Corporation

15. Strategic Recommendations